Mycophenolate vs Azathioprin in Autoimmune Hepatitis

Reappraisal of the Therapies of Refractory Autoimmune Hemolytic Anemia in Systemic Lupus Erythematosus

NCT05057481 ·Status: UNKNOWN ·Phase: PHASE3

Weaning of Immunosuppression in Nephritis of Lupus

NCT01284725 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis

NCT04186871 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Clinical Effects of Azathioprine and Rituximab NMO-SD Patients

NCT03002038 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study Medication Adherence and Its Determinants in Chronic Disease Through the Example of Methotrexate in Chronic Inflammatory Rheumatism

NCT02926560 ·Status: COMPLETED

A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

NCT04895696 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Treatment Strategies for IgG4-RD Patients With Internal Organ Involvement

NCT05789017 ·Status: RECRUITING ·Phase: NA

Fixed-dose Versus Concentration-controlled Mycophenolate Mofetil for the Treatment of Active Lupus Nephritis

NCT03920059 ·Status: TERMINATED ·Phase: PHASE4

Comparison of the Efficacy of Leflunomide and Azathioprine for the Maintenance Therapy of ANCA Associated Vasculitis

NCT04737343 ·Status: UNKNOWN ·Phase: NA

Cyclophosphamide Versus Mycophenolate Mofetil in Lupus Nephritis

NCT03200002 ·Status: COMPLETED ·Phase: PHASE2

Exploratory Study of Changes in Disease Activity and Biomarkers With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE)

NCT00997100 ·Status: COMPLETED ·Phase: PHASE2

The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis

NCT02954939 ·Status: RECRUITING ·Phase: NA

Autoimmunity in Retinitis Pigmentosa

NCT00433277 ·Status: UNKNOWN ·Phase: NA

COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

NCT05000216 ·Status: TERMINATED ·Phase: PHASE2

IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic Vasculitis

NCT00307645 ·Status: TERMINATED ·Phase: PHASE3

Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis

NCT01172002 ·Status: UNKNOWN ·Phase: NA

The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From Practice

NCT04558203 ·Status: COMPLETED

Myfortic Versus Azathioprine in Systemic Lupus Erythematosus

NCT00504244 ·Status: TERMINATED ·Phase: PHASE3

Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)

NCT01946880 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

NCT01714817 ·Status: TERMINATED ·Phase: PHASE3

Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Nephritis

NCT00371319 ·Status: COMPLETED ·Phase: PHASE4

Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum Disorder

NCT05896605 ·Status: COMPLETED ·Phase: PHASE4

Treatment Strategies in IgG4-RD Patients With Re-elevation of Serum IgG4 Level During Maintenance Remission Period

NCT05974683 ·Status: NOT_YET_RECRUITING ·Phase: NA

The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis

NCT00573157 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

miR-101-3p and Autotaxin in SLE Patients

NCT07252141 ·Status: NOT_YET_RECRUITING